Literature DB >> 27794120

BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence.

Yohei Hayashi1,2, Edward C Hsiao3, Salma Sami4, Mariselle Lancero4, Christopher R Schlieve4,5,6, Trieu Nguyen4, Koyori Yano7, Ayako Nagahashi7, Makoto Ikeya8, Yoshihisa Matsumoto9,10,11, Ken Nishimura2, Aya Fukuda2, Koji Hisatake2, Kiichiro Tomoda4, Isao Asaka7, Junya Toguchida9,10,12, Bruce R Conklin4,3,13, Shinya Yamanaka1,8.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) patients carry a missense mutation in ACVR1 [617G > A (R206H)] that leads to hyperactivation of BMP-SMAD signaling. Contrary to a previous study, here we show that FOP fibroblasts showed an increased efficiency of induced pluripotent stem cell (iPSC) generation. This positive effect was attenuated by inhibitors of BMP-SMAD signaling (Dorsomorphin or LDN1931890) or transducing inhibitory SMADs (SMAD6 or SMAD7). In normal fibroblasts, the efficiency of iPSC generation was enhanced by transducing mutant ACVR1 (617G > A) or SMAD1 or adding BMP4 protein at early times during the reprogramming. In contrast, adding BMP4 at later times decreased iPSC generation. ID genes, transcriptional targets of BMP-SMAD signaling, were critical for iPSC generation. The BMP-SMAD-ID signaling axis suppressed p16/INK4A-mediated cell senescence, a major barrier to reprogramming. These results using patient cells carrying the ACVR1 R206H mutation reveal how cellular signaling and gene expression change during the reprogramming processes.

Entities:  

Keywords:  BMP; FOP; pluripotency; reprogramming; senescence

Mesh:

Substances:

Year:  2016        PMID: 27794120      PMCID: PMC5135304          DOI: 10.1073/pnas.1603668113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

Review 1.  Id: a target of BMP signaling.

Authors:  Kohei Miyazono; Keiji Miyazawa
Journal:  Sci STKE       Date:  2002-09-24

2.  Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression.

Authors:  Elizabeth E Romero-Lanman; Svetlana Pavlovic; Bhishma Amlani; Yvette Chin; Robert Benezra
Journal:  Stem Cells Dev       Date:  2011-12-01       Impact factor: 3.272

3.  Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells.

Authors:  A Hollnagel; V Oehlmann; J Heymer; U Rüther; A Nordheim
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

4.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Authors:  D Lyden; A Z Young; D Zagzag; W Yan; W Gerald; R O'Reilly; B L Bader; R O Hynes; Y Zhuang; K Manova; R Benezra
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

5.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

6.  TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells.

Authors:  Daylon James; Ariel J Levine; Daniel Besser; Ali Hemmati-Brivanlou
Journal:  Development       Date:  2005-02-09       Impact factor: 6.868

7.  Senescence impairs successful reprogramming to pluripotent stem cells.

Authors:  Ana Banito; Sheikh T Rashid; Juan Carlos Acosta; SiDe Li; Carlos F Pereira; Imbisaat Geti; Sandra Pinho; Jose C Silva; Veronique Azuara; Martin Walsh; Ludovic Vallier; Jesús Gil
Journal:  Genes Dev       Date:  2009-08-20       Impact factor: 11.361

8.  ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A.

Authors:  Sarah J Hatsell; Vincent Idone; Dana M Alessi Wolken; Lily Huang; Hyon J Kim; Lili Wang; Xialing Wen; Kalyan C Nannuru; Johanna Jimenez; Liqin Xie; Nanditha Das; Genevieve Makhoul; Rostislav Chernomorsky; David D'Ambrosio; Richard A Corpina; Christopher J Schoenherr; Kieran Feeley; Paul B Yu; George D Yancopoulos; Andrew J Murphy; Aris N Economides
Journal:  Sci Transl Med       Date:  2015-09-02       Impact factor: 17.956

9.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Authors:  Angel Raya; Ignasi Rodríguez-Pizà; Guillermo Guenechea; Rita Vassena; Susana Navarro; María José Barrero; Antonella Consiglio; Maria Castellà; Paula Río; Eduard Sleep; Federico González; Gustavo Tiscornia; Elena Garreta; Trond Aasen; Anna Veiga; Inder M Verma; Jordi Surrallés; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

10.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

View more
  27 in total

Review 1.  Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.

Authors:  Emilie Barruet; Edward C Hsiao
Journal:  Bone       Date:  2017-07-14       Impact factor: 4.398

2.  dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.

Authors:  Giulia Santinon; Irene Brian; Arianna Pocaterra; Patrizia Romani; Elisa Franzolin; Chiara Rampazzo; Silvio Bicciato; Sirio Dupont
Journal:  EMBO J       Date:  2018-04-12       Impact factor: 11.598

3.  Selective targeting of TET catalytic domain promotes somatic cell reprogramming.

Authors:  Anup Kumar Singh; Bo Zhao; Xiuhua Liu; Xin Wang; Hongzhi Li; Hanjun Qin; Xiwei Wu; Yuelong Ma; David Horne; Xiaochun Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-05       Impact factor: 11.205

Review 4.  Fibrodysplasia ossificans progressiva: Basic understanding and experimental models.

Authors:  Zijuan Qi; Jing Luan; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2017-11

5.  Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.

Authors:  Ryu Watanabe; Tsuyoshi Shirai; Hong Namkoong; Hui Zhang; Gerald J Berry; Barbara B Wallis; Benedikt Schaefgen; David G Harrison; Jennifer A Tremmel; John C Giacomini; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

Review 6.  The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer.

Authors:  Justyna Mikuła-Pietrasik; Szymon Rutecki; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2022-03-19       Impact factor: 9.261

7.  Cellular direct conversion by cell penetrable OCT4-30Kc19 protein and BMP4 growth factor.

Authors:  Seung Hyun L Kim; Sungwoo Cho; Seoyeon Kim; Janet Kwon; Jaeyoung Lee; Rachel H Koh; Ju Hyun Park; Hwajin Lee; Tai Hyun Park; Nathaniel S Hwang
Journal:  Biomater Res       Date:  2022-07-14

8.  Clearance of Senescent Cells From Injured Muscle Abrogates Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.

Authors:  Haitao Wang; Qiang Zhang; Frederick S Kaplan; Robert J Pignolo
Journal:  J Bone Miner Res       Date:  2021-10-25       Impact factor: 6.390

9.  The whole profiling and competing endogenous RNA network analyses of noncoding RNAs in adipose-derived stem cells from diabetic, old, and young patients.

Authors:  Sen Ren; Hewei Xiong; Jing Chen; Xiaofan Yang; Yutian Liu; Jiahe Guo; Tao Jiang; Zhao Xu; Meng Yuan; Yang Liu; Nan Zhou; Hongrui Chen; Wenqing Li; Hans-Günther Machens; Zhenbing Chen
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

10.  Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration.

Authors:  Frank Arnold; Pallavi U Mahaddalkar; Johann M Kraus; Xiaowei Zhong; Wendy Bergmann; Dharini Srinivasan; Johann Gout; Elodie Roger; Alica K Beutel; Eugen Zizer; Umesh Tharehalli; Nora Daiss; Ronan Russell; Lukas Perkhofer; Rupert Oellinger; Qiong Lin; Ninel Azoitei; Frank-Ulrich Weiss; Markus M Lerch; Stefan Liebau; Sarah-Fee Katz; André Lechel; Roland Rad; Thomas Seufferlein; Hans A Kestler; Michael Ott; Amar Deep Sharma; Patrick C Hermann; Alexander Kleger
Journal:  Adv Sci (Weinh)       Date:  2021-05-13       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.